SNDX - Syndax Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5244.81M
Enterprise Value 3172.77M
Trailing P/E N/A
Forward P/E 1-4.96
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)161.38
Price/Book (mrq)5.56
Enterprise Value/Revenue 3113.89
Enterprise Value/EBITDA 6-2.76

Trading Information

Stock Price History

Beta (5Y Monthly) 2.46
52-Week Change 364.96%
S&P500 52-Week Change 325.98%
52 Week High 311.11
52 Week Low 34.52
50-Day Moving Average 38.56
200-Day Moving Average 38.26

Share Statistics

Avg Vol (3 month) 3112.59k
Avg Vol (10 day) 3131.66k
Shares Outstanding 527.14M
Float 18.98M
% Held by Insiders 16.11%
% Held by Institutions 173.29%
Shares Short (Dec. 30, 2019) 4606.46k
Short Ratio (Dec. 30, 2019) 44.85
Short % of Float (Dec. 30, 2019) 42.57%
Short % of Shares Outstanding (Dec. 30, 2019) 42.23%
Shares Short (prior month Nov. 28, 2019) 4528.7k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2018
Most Recent Quarter (mrq)Sep. 29, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-4,130.98%

Management Effectiveness

Return on Assets (ttm)-45.32%
Return on Equity (ttm)-112.42%

Income Statement

Revenue (ttm)1.52M
Revenue Per Share (ttm)0.05
Quarterly Revenue Growth (yoy)0.00%
Gross Profit (ttm)1.52M
EBITDA -62.59M
Net Income Avi to Common (ttm)-60.88M
Diluted EPS (ttm)-2.08
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)73.04M
Total Cash Per Share (mrq)2.69
Total Debt (mrq)1M
Total Debt/Equity (mrq)2.28
Current Ratio (mrq)4.09
Book Value Per Share (mrq)1.62

Cash Flow Statement

Operating Cash Flow (ttm)-52.93M
Levered Free Cash Flow (ttm)-29.91M